Levodopa-induced dyskinesias in parkinsonian monkeys: Relationship to extent of nigrostriatal damage
- 1 September 1989
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 34 (1), 193-196
- https://doi.org/10.1016/0091-3057(89)90372-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Journal of the Neurological Sciences, 1987
- Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's diseaseAnnals of Neurology, 1987
- Chronic treatment withl-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone bindingBrain Research, 1986
- Long‐term follow‐up of early dopa treatment in Parkinson's diseaseAnnals of Neurology, 1986
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985
- Evidence to support early levodopa therapy in Parkinson diseaseNeurology, 1981
- Analysis of the clinical problems in parkinsonism and the complications of long‐term levodopa therapyNeurology, 1979
- “On‐off” phenomenon with levodopa therapy in parkinsonismNeurology, 1974
- Analysis of L-dopa induced dyskinesias in 51 patients with ParkinsonismJournal of Neurology, Neurosurgery & Psychiatry, 1971